Synthesis, structural characterization and anticancer activity of some new complexes of 6-amino-4-hydroxy-2-thiopyrimidine

[1]  I. Butler,et al.  Preparation, characterization and pH-metric measurements of 4-hydroxysalicylidenechitosan Schiff-base complexes of Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Ru(III), Rh(III), Pd(II) and Au(III). , 2011, Carbohydrate research.

[2]  S. I. Mostafa,et al.  pH-metric and spectroscopic properties of new 4-hydroxysalicylidene-2-aminopyrimidine Schiff-base transition metal complexes , 2010 .

[3]  D. R. Patil,et al.  A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity. , 2009, European journal of medicinal chemistry.

[4]  S. I. Mostafa,et al.  Synthesis, characterization and anticancer activity of 3-aminopyrazine-2-carboxylic acid transition metal complexes , 2009 .

[5]  G. Tamasi,et al.  Ruthenium-thiobase complexes: Synthesis, spectroscopy, density functional studies for trans,cis,cis-[RuII(AsPh3)2 (N,S-2-Thiopyrimidinato)2] and structural analysis of selected weak C–H⋯N and C–H⋯S interactions , 2009 .

[6]  J. Ellena,et al.  Rhenium chelate complexes with maltolate or kojate , 2008 .

[7]  S. I. Mostafa.  Synthesis, characterization and antineoplastic activity of 5-chloro-2,3-dihydroxypyridine transition metal complexes , 2008 .

[8]  S. I. Mostafa,et al.  Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2′-Bipyridyl , 2008, Metal-based drugs.

[9]  N. Hadjiliadis,et al.  Biologically active 2-thione-4,6-diamino-5-hydroxypyrimidine transition metal complexes , 2008 .

[10]  D. Vos,et al.  Synthesis, characterization and in vitro cytotoxicity of homobimetallic complexes of palladium(II) with 2-thiouracil ligands. Crystal structure of [Pd2(TU)(PPh3)3Cl2] , 2007 .

[11]  S. I. Mostafa.  Mixed ligand complexes with 2-piperidine-carboxylic acid as primary ligand and ethylene diamine, 2,2′-bipyridyl, 1,10-phenanthroline and 2(2′-pyridyl)quinoxaline as secondary ligands: preparation, characterization and biological activity , 2007 .

[12]  J. Collins,et al.  The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators. , 2007, Journal of inorganic biochemistry.

[13]  A. Spek,et al.  Synthesis, characterization, and DNA-binding studies of nitro(oligopyridine)ruthenium(II) complexes. , 2006, Inorganic chemistry.

[14]  T. Hambley,et al.  Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug. , 2006, Biochemical pharmacology.

[15]  M. A. Kabil,et al.  Ligational and analytical applications of a uracil derivative toward some transition metal ions , 2006 .

[16]  M. Jakupec,et al.  The first metal-based paullone derivative with high antiproliferative activity in vitro. , 2006, Inorganic chemistry.

[17]  E. López-Torres,et al.  Complexes of a triazine-3-thione ligand with divalent metals: Crystal structure of [CdL2DMF]2 · 2DMF · 1/4H2O , 2005 .

[18]  Yang Shi,et al.  Syntheses, characterization and crystal structures of diorganotin compounds with 2-mercaptopyrimidine and 4-amino-2-mercaptopyrimidine , 2005 .

[19]  J. Pons,et al.  Synthesis, spectroscopic properties and structural characterisation of Pd(II) and Pt(II) complexes with 1,3,5-pyrazole derived ligands. Rotation around the metal–N bond , 2005 .

[20]  B. Lippert.  Alterations of Nucleobase pKa Values upon Metal Coordination: Origins and Consequences , 2005 .

[21]  A. Lansdown,et al.  Silver. 2: Toxicity in mammals and how its products aid wound repair. , 2002, Journal of wound care.

[22]  A. Lansdown,et al.  Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.

[23]  A. Terzis,et al.  Reactions of 2,2′-bipyridine (bpy) and 1,10-phenanthroline (phen) with yttrium(III) nitrate: preparation, X-ray crystal structures and spectroscopic characterization of the bis-bpy and bis-phen complexes , 2001 .

[24]  C. Sinha,et al.  Reaction of Ru(PPh3)3Cl2 with 2-(arylazo)pyrimidines. Spectral and redox characterisation of the products.: Part V. Single crystal X-ray structure of Ru(PPh3)2(papm)Cl2 (papm=2-(phenylazo)pyrimidine) , 2001 .

[25]  M. Kubicki,et al.  Organotin adducts with pyrimidinethione: crystal structure of dimethyldi(pyrimidine‐2‐thiolato)tin(IV) and diphenyldi(pyrimidine‐2‐thiolato)tin(IV) , 2000 .

[26]  D. Vikić-Topić,et al.  Mercury(II) complexes of heterocyclic thiones. Part 1. Preparation of 1:2 complexes of mercury(II) halides and pseudohalides with 3, 4, 5, 6-tetrahydropyrimidine-2-thione. X-ray, thermal analysis and NMR studies , 2000 .

[27]  K. Raymond,et al.  Synthesis of a ligand based upon a new entry into the 3-hydroxy-N-alkyl-2(1H)-pyridinone ring system and thermodynamic evaluation of its gadolinium complex. , 2000, Inorganic chemistry.

[28]  M. Bekheit,et al.  Synthesis and structure studies of complexes of some second row transition metals with 1-(phenylacetyl and phenoxyacetyl)-4-phenyl-3-thiosemicarbazide. , 2000, Chemical & pharmaceutical bulletin.

[29]  D. Vikić-Topić,et al.  Preparation and spectroscopic properties of the complexes of mercuric thiocyanate with pyridine-2-thione and pyridine-2-carboxylic acid. , 1999 .

[30]  S. I. Mostafa,et al.  Synthesis and Characterization of Some Transition Metal Complexes of 2-Amino-3-hydroxypyridine and its Application in Corrosion Inhibition , 1998 .

[31]  M. N. Srivastava,et al.  Synthesis and Characterization of Complexes of Copper(II), Nickel(II), Cobalt(II) and Zinc(II) with Alanine and Uracil or 2-Thiouracil , 1996 .

[32]  G. Natile,et al.  A trans-platinum complex showing higher antitumor activity than the cis congeners. , 1993, Journal of medicinal chemistry.

[33]  W. Griffith,et al.  Complexes of esculetin with second and third row transition elements , 1992 .

[34]  C. Orvig,et al.  Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones , 1991 .

[35]  W. Gispen,et al.  Neurotoxic side-effects of cisplatin. , 1991, European journal of cancer.

[36]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[37]  J. M. Salas,et al.  Spectroscopic studies of some Pd(II), Pt(II), Ag(I), and Au(III) complexes of 4,6-diamino-2-thiopyrimidine and 4,6-diamino-2-methylthiopyrimidine. Structure and binding site determination , 1988 .

[38]  S. Aruna,et al.  Vibrational assignments of six-membered heterocyclic compounds: Normal vibrations of 6-amino uracil and 6-amino 2-thio uracil , 1985 .

[39]  M. F. Gillen,et al.  Uracil analogues of the acyclonucleoside 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]- methyl]guanine (BIOLF-62) , 1984 .